U.S. markets closed

Prenetics Global Limited (PRE)

NasdaqGM - NasdaqGM Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
6.08+0.01 (+0.16%)
Al cierre: 04:00PM EDT

Prenetics Global Limited

Unit 703-706, K11 Atelier King’s Road
728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com

Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo: 320

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Sheng Wu YeungCo-Founder, Chairperson & CEON/DN/D1979
Dr. Chi Hung Tzang Ph.D.Co-Founder, Chief Scientific Officer & Member of Scientific Advisory BoardN/DN/D1975
Mr. Hoi Chun LoChief Financial OfficerN/DN/D1985
Dr. Yung Ho Wong DPHILChief Technology OfficerN/DN/D1982
Ms. Samantha KwokChief of Staff to Group CEO & Vice President, People & OperationsN/DN/DN/D
Dr. Senthil Sundaram M.D.Chief Clinical OfficerN/DN/D1974
Mr. Joel NeohChief Consumer Officer & Chief Executive Officer for CircleDNAN/DN/D1984
Mr. Walt LingChief Executive Officer of ACT GenomicsN/DN/DN/D
Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test. It also provides Insighta develops and commercializes multi-cancer early detection technology named Fragma. In addition, the company, through acquisition of ACT Genomics, which is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug. Further, the company offers ACTLiquid Pro, an NGS-based liquid biopsy assay for pan-solid tumors; ACTMonitor which provides realtime monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.

Gestión corporativa

La calificación ISS Governance QuickScore de Prenetics Global Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.